StockTipsArenaBeta

BUY Cipla Ltd. — IDBI Capital

BUYCipla Ltd.

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))21 Sept 2026via IDBI Capital Research Calls Telegram

Entry₹1,400Stated
Target₹1,465
Total upside +4.64% (call closed)
Stop loss₹1,365-2.50% risk
Exit₹1,36522 Sept 2026, 11:05 am
Stop-loss hit-2.50%
Follow IDBI Capital for new calls(28% target hit, 262 closed calls)Get alertsWatch CIPLA for new buy/sell callsGet alertsSee 182 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Sept, 8:43 pm IST
3 supporting2 neutral1 opposing
Supports the BUY call (3)

3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·21 Sept · today

Wockhardt Share Price Today: 2.19% rise and sector view

NewsGoogle News·17 Sept · 4d ago

(opens in new tab)

Kopran Ltd. Share Price Rises 8.83% Today

NewsGoogle News·15 Sept · 6d ago

(opens in new tab)
Neutral / worth noting (2)

Anthem Biosciences Share Price Today: valuation and peers

NewsGoogle News·18 Sept · 3d ago

(opens in new tab)

SYMBIOTEC Share Price News: price rise and valuation view

NewsGoogle News·18 Sept · 3d ago

(opens in new tab)
Weighs against the BUY call (1)

US Drug Tariff: 15 Pharma Stocks Likely to Be Impacted by Trump’s New Tariff Plan

NewsGoogle News·16 Sept · 5d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.